The EPS beat and debt refinancing are positive, but the reaffirmation of existing guidance without an upgrade limits the upside catalyst.
Price Chart
Executive Summary
OptimizeRx reported Q2 2026 revenue of $20.5M and EPS of $0.14, beating consensus estimates of $20.2M and $0.11 respectively (25% EPS beat). The company reaffirmed FY2026 revenue guidance of $95-$100M and adjusted EBITDA guidance of $21-$25M, while completing a $35M debt refinancing that improved its capital structure. The beat is notable but tempered by a net loss of $(0.7)M and the reaffirmation of existing guidance rather than an upgrade, suggesting limited near-term upside catalyst.
Key Financial Metrics
Key Facts
- Q2 2026 revenue of $20.5M vs consensus $20.2M (beat)
- EPS of $0.14 vs consensus $0.11 (25% beat)
- Net loss of $(0.7) million in Q2
- Adjusted EBITDA of $4.9 million in Q2
- Reaffirmed FY2026 revenue guidance of $95-$100 million
- Reaffirmed FY2026 adjusted EBITDA guidance of $21-$25 million
- Completed $35 million debt refinancing with $25M term loan and $10M undrawn revolver
- Repaid $8.3 million of principal since inception of new facility
Financial Impact
EPS beat by 25% ($0.14 vs $0.11) on revenue of $20.5M; net loss of $(0.7)M; adjusted EBITDA of $4.9M; FY2026 guidance unchanged at $95-$100M revenue and $21-$25M adjusted EBITDA
Risk Factors
- Net loss of $(0.7)M indicates ongoing profitability challenges
- Guidance reaffirmed but not raised, capping near-term upside
- Debt refinancing adds $25M term loan, increasing leverage despite improved terms
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3344034 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | SC 13G/A | $9.37 | awaiting T+20 | — | $9.07 (−3.20%) |
Sep 22, 2026 4w ago | Institutional Cluster | $7.62 $8.93 | ▲ +17.19% | ▲ +17.75% | $9.07 (+19.03%) |
Aug 12, 2026 10w ago | Press Release | $8.78 $7.29 | ▼ −16.97% | ▼ −15.22% | $9.07 (+3.30%) |
Jun 12, 2026 19w ago | 8-K | $5.32 $6.55 | ▲ +23.12% | ▲ +23.87% | $9.07 (+70.49%) |
Jun 11, 2026 19w ago | Institutional Cluster | $5.28 $6.28 | ▲ +18.94% | ▲ +17.05% | $9.07 (+71.78%) |
Jun 5, 2026 20w ago | 8-K | $5.05 $6.35 | ▲ +25.74% | ▲ +24.11% | $9.07 (+79.60%) |
Jun 1, 2026 21w ago | DEFA14A | $5.38 $5.72 | ▲ +6.32% | ▲ +7.62% | $9.07 (+68.59%) |
May 21, 2026 22w ago | Press Release | $4.94 $4.70 | ▼ −4.86% | ▼ −5.19% | $9.07 (+83.60%) |
May 12, 2026 23w ago | Press Release | $4.92 $5.28 | ▲ +7.32% | ▲ +7.93% | $9.07 (+84.35%) |
Mar 5, 2026 33w ago | Press Release | $6.74 $6.80 | ▲ +0.89% | ▲ +2.93% | $9.07 (+34.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers